Your browser doesn't support javascript.
loading
Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer.
Hanauske, A-R; Lahn, M; Musib, L C; Weigang-Köhler, K; Yilmaz, E; Graefe, T; Kuenen, B; Thornton, D; McNealy, P; Giaccone, G.
Afiliação
  • Hanauske AR; I. Medical Department, General Hospital, St Georg, Hamburg, Germany.
  • Lahn M; Early Phase Clinical Oncology Development, Eli Lilly and Company, Indianapolis, IN, USA.
  • Musib LC; Early Phase Clinical Oncology Development, Eli Lilly and Company, Indianapolis, IN, USA.
  • Weigang-Köhler K; Medical Clinic 5, Oncology and Hematology, Clinic Nürnberg Nord, Nürnberg.
  • Yilmaz E; I. Medical Department, General Hospital, Hamburg, Germany.
  • Graefe T; I. Medical Department, General Hospital, Hamburg, Germany.
  • Kuenen B; Department of Medical Oncology, VU Medical Center, Amsterdam, Netherlands.
  • Thornton D; Early Phase Clinical Oncology Development, Eli Lilly and Company, Indianapolis, IN, USA.
  • McNealy P; Early Phase Clinical Oncology Development, Eli Lilly and Company, Indianapolis, IN, USA.
  • Giaccone G; Department of Medical Oncology, VU Medical Center, Amsterdam, Netherlands. Electronic address: giacconeg@mail.nih.gov.
Ann Oncol ; 20(9): 1565-1575, 2009 Sep.
Article em En | MEDLINE | ID: mdl-19487488
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Idioma: En Ano de publicação: 2009 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Idioma: En Ano de publicação: 2009 Tipo de documento: Article